| Not Yet Recruiting | Acotiamide vs Itopride in Postprandial Distress Syndrome Postprandial Distress Syndrome | Phase 3 | 2025-10-30 |
| Not Yet Recruiting | Diabetes Foot Africa Region Registry Diabetes | — | 2025-08-01 |
| Not Yet Recruiting | Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population Diabetes Mellitus, Diabetes Mellitus, Adult-Onset, Diabetes Mellitus Type 1 and 2 | — | 2025-02-01 |
| Completed | Medical Stone Expulsive Therapy for Acutely Obstructed Ureteric Calculi Ureteric Stone of Lower Third of Ureter | Phase 4 | 2024-09-01 |
| Recruiting | Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFL Liver Fat, Liver Fibrosis, Glycemic Control | Phase 4 | 2023-03-01 |
| Completed | Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study Efficacy, Safety, Tolerability | — | 2022-12-01 |
| Unknown | Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis, NAFLD | Phase 4 | 2021-09-15 |
| Recruiting | Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Stu Type II Diabetes Mellitus, Efficacy, Self, Safety Issues | Phase 4 | 2021-04-01 |
| Completed | Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Pat Quality of Life, Type 2 Diabetes, Metformin+Sitagliptin | Phase 4 | 2021-01-01 |
| Completed | Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus Adverse Drug Event, Effect of Drug, Type 2 Diabetes Treated With Insulin | Phase 4 | 2021-01-01 |
| Completed | Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 4 | 2020-07-01 |
| Completed | Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus Type II Diabetes Mellitus | Phase 4 | 2019-06-01 |
| Completed | Direct Acting Anti-Viral's In Chronic HCV Patients Safety Issues | — | 2018-05-15 |
| Completed | Knowledge and Practices of ADR Reporting in LMICs Adverse Reaction | — | 2017-04-01 |
| Completed | Effect of Ivabradine in Lowering Heart Rate and Quality of Life in Chronic Heart Failure Patients Chronic Heart Failure | — | 2016-12-01 |
| Completed | Zurig (Febuxostat) 40mg Efficacy and Safety Trial Hyperuricemia | Phase 4 | 2013-11-01 |
| Completed | Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population Hepatitis C | Phase 4 | 2010-08-01 |